ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance

Wu, Chunrong; Sun, Guiyin*; Wang, Fan; Chen, Jiangyan; Zhan, Fangbiao; Lian, Xiaojuan; Wang, Jie; Weng, Fanbin; Li, Bo; Tang, Weijun; Quan, Jin; Xiang, Debing*重庆大学
Scientific Reports2022-12-28DOI: 10.1038/s41598-022-25053-0
3被引23阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is among the most prominent causes of cancer-associated mortality in the world, with chemoresistance representing one of the leading causes of treatment failure. However, the mechanisms governing such chemoresistance remain incompletely understood. In this study, the role of DYRK2 as a mediator of CRC cell drug resistance and the associated molecular mechanisms were assessed by evaluating human tumor tissue samples, CRC cell lines, and animal model systems. Initial analyses of The Cancer Genome Atlas database and clinical tissue microarrays revealed significant DYRK2 downregulation in CRC in a manner correlated with poor prognosis. We further generated LoVo CRC cells that were resistant to the chemotherapeutic drug 5-FU, and found that such chemoresistance was associated with the downregulation of DYRK2 and a more aggressive mesenchymal phenotype. When DYRK2 was overexpressed in these cells, their proliferative, migratory, and invasive activities were reduced and they were more prone to apoptotic death. DYRK2 overexpression was also associated with enhanced chemosensitivity and the inhibition of epithelial-mesenchymal transition (EMT) induction in these LoVo 5-FUR cells. Co-immunoprecipitation assays revealed that DYRK2 bound to Twist and promoted its proteasomal degradation. In vivo studies further confirmed that the overexpression of DYRK2 inhibited human CRC xenograft tumor growth with concomitant Twist downregulation. Overall, these results thus highlight DYRK2 as a promising therapeutic target in CRC worthy of further investigation.

学科与关键词

关键词
POOR-PROGNOSISEXPRESSIONPROMOTESMETASTASISPLASTICITYRESISTANCEMARKER
相关
加载中…
  • LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer
    Yao, Fei; Huang, Xiaoying; Xie, Zhufu; Chen, Jie; Zhang, Ling; Wang, Qiang; Long, Hui; Jiang, Jue*; Wu, Qingming*Carcinogenesis, 2022, 43(9): 895-907.被引 3
  • KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2
    Ye, Feng; Xie, Yuwen; Lin, Mingdao; Liu, Yang; Fang, Yuan; Chen, Keli; Zhang, Yaowei; Ding, Yi*Molecular and Cellular Biochemistry, 2023.
  • SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer
    Zhu, Yin; Huang, Shimiao; Chen, Shengyuan; Chen, Jiaxuan; Wang, Zhiqing; Wang, Yadong; Zheng, Haoxuan*Cell Death & Disease, 2021, 12(5): 449.被引 67
查看全部 →

发表信息

论文状态
公开发表
期刊
Scientific Reports
发表日期
2022-12-28
卷期
第 12 卷, 第 1 期
页码
22496
DOI
10.1038/s41598-022-25053-0
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
General project of Chongqing Natural Science Foundation [Cstc2019jcyj-msxmX0627, Cstc2020jcyj-msxmX0183]; Talents project of Chongqing, China [CQYC202103063]

作者

  • W

    Wu, Chunrong (第一作者)

    jiangjin cent hosp · chongqing univ

  • S

    Sun, Guiyin (通讯)

    jiangjin cent hosp · chongqing univ

查看全部 12 位作者收起作者
  • W

    Wang, Fan

    jiangjin cent hosp · chongqing univ

  • C

    Chen, Jiangyan

    jiangjin cent hosp · chongqing univ

  • Z

    Zhan, Fangbiao

    chongqing univ

  • L

    Lian, Xiaojuan

    jiangjin cent hosp · chongqing univ

  • W

    Wang, Jie

    jiangjin cent hosp · chongqing univ

  • W

    Weng, Fanbin

    jiangjin cent hosp · chongqing univ

  • L

    Li, Bo

    chongqing univ

  • T

    Tang, Weijun

    jiangjin cent hosp · chongqing univ

  • Q

    Quan, Jin

    jiangjin cent hosp · chongqing univ

  • X

    Xiang, Debing (通讯)

    jiangjin cent hosp · chongqing univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417